Abrika Pharmaceuticals Overview
- Year Founded
-
2002
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$110M
Abrika Pharmaceuticals General Information
Description
Developer of drug delivery technologies. The company manufactures generic pharmaceutical products and proprietary drugs for tablets and capsules. The company's products include pellets, microparticles, coated granules, transmucosal and transdermal delivery.
Contact Information
Primary Industry
Drug Delivery
Other Industries
Other Healthcare Technology Systems
Drug Discovery
Acquirer
Primary Office
- 13800 North West 2nd Avenue
- Suite 190
- Sunrise, FL 33325
- United States
+1 (954) 000-0000
Abrika Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 23-Apr-2007 | $110M | 00000 | Completed | Generating Revenue | |
| 1. Early Stage VC | Completed | Startup |
Abrika Pharmaceuticals Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Signet Healthcare Partners | Growth/Expansion | Minority | 000 0000 | 000000 0 |